Quantcast
Nimbus Healthcare

Our Quality and Safety Practices

Expanding Access to High-Quality Obesity Care

At Nimbus Healthcare, we recognize the longstanding barriers faced by individuals living with obesity. These challenges include limited treatment options, deep-rooted weight bias, scarce insurance coverage, and inconsistent access to essential medications such as GLP-1s. As a company founded by a compounding pharmacist, we excel in creating and assessing high-quality compounds. Our mission is to make effective obesity treatments more accessible and to uphold the highest standards of care.

We actively work through the complexities of the insurance system on behalf of our patients, secure a reliable supply of medications at pharmacies, and provide both compounded Semaglutide and Tirzepatide. Our commitment extends beyond mere access, focusing on continuous, superior care.


Why Nimbus Offers Compounded Options

Compounded Semaglutide and Tirzepatide
At Nimbus Healthcare, we believe that everyone who can benefit from GLP-1s should have access to these medications. We offer compounded versions of both Semaglutide and Tirzepatide, which are formulated using the same active pharmaceutical ingredients as their branded counterparts, without including any salts. Although compounded drugs do not undergo FDA approval, our foundation in compounding pharmacy drives us to independently ensure the utmost quality and safety of our products.


Qualifying for Treatment

Eligibility and Prescription Process
Our treatments, including compounded Semaglutide and Tirzepatide, are available to patients for whom they are safe and appropriate, as determined by a licensed provider. Prospective patients begin by completing an online visit to share their medical history and health goals. A Nimbus-affiliated provider may then order metabolic lab tests to further understand the patient’s health. Based on this comprehensive evaluation, the provider will discuss the potential benefits and risks, choosing between compounded or branded options.

Ongoing Support for Patients
Patients prescribed any GLP-1 medication receive comprehensive support through our Body Program. This includes regular consultations with healthcare providers, personalized coaching from nurses, 24/7 messaging support, progress tracking, and an educational curriculum, ensuring a well-rounded care experience.


Our Expertise in Compounding

Safety and Quality Assurance
Leveraging our deep expertise in compounding pharmacy, Nimbus collaborates with accredited compounding pharmacies that strictly adhere to sterile compounding regulations and source their active pharmaceutical ingredients from FDA-registered suppliers. We conduct extensive quality assurance and control checks for every batch, including potency, sterility, and endotoxicity tests performed by independent third-party labs. We ensure that each batch meets our stringent standards before it is dispensed.

Tracking and Addressing Side Effects
We employ a robust system to monitor and swiftly respond to any reported side effects. This system includes mandatory check-ins, enabling real-time communication with healthcare providers, and detailed tracking of treatment batches for quick response to adverse events.


Conclusion

Nimbus Healthcare is redefining the landscape of obesity care by providing accessible, high-quality treatments tailored to our patients' needs. Our roots in compounding pharmacy and our relentless pursuit of excellence in every compound we create and assess underline our commitment to not just meet but exceed the expectations of those we serve.

Nimbus in the news